Giuseppe Conte

TL;DR: In chronic kidney disease, ambulatory BP measurement and, in particular, nighttime BP measurement, allows more accurate prediction of renal and cardiovascular risk; office measurement of BP does not predict any outcome.

TL;DR: A high BMI predicts onset of albuminuria without kidney failure (CKD stages 1-2) as well as CKD stages 3 and higher, the effect being significant only in obese individuals.

TL;DR: An immediate GFR decline proportional to the osmolarity of CM and secondary to the renal hypoperfusion that is neither caused by hypovolemia nor mediated by ET-1, an early tubular dysfunction at the level of the proximal nephron, and a protective effect of single-dose pretreatment with either captopril or nifedipine on D-induced acute and short-term GFR changes are found.

TL;DR: It is suggested that efficacious salt restriction in CRF patients improves the outcome of renal disease independent from its antihypertensive effects.

TL;DR: In CKD, pseudoresistance is not associated with an increased cardio-renal risk, and sustained hypertension predicts only renal outcome, and true resistance is prevalent and identifies patients carrying the highest cardiovascular risk.